Journal Nature: Scientists identify the brain cells that regulate inflammation, and pinpoint how they keep tabs on the immune response. They detect immunological stimuli from the body's periphery and help control the immune response.
nature.com/articles/d4158… Atanas G. Atanasov

Offline: It is time to take cancer more seriously - The Lancet thelancet.com/journals/lance…

The Full Report of the WHO Expert Committee on Selection and Use of Essential Medicines, 2023
is finally out
who.int/publications/i…

Promoting evidence-based medicine and health care

The use of artificial intelligence (AI) in health care has seen remarkable growth in the past 5 years.

A new Review from The Lancet Digital Health examines how AI could improve care management, clinical decision-making efficiency, and further research areas 👉 hubs.li/Q02v0wl50

Revising the procedures for updating WHO’s model lists of essential medicines: consultation report

who.int/publications/i…

Randomised controlled trials evaluating artificial intelligence in clinical practice: a scoping review - The Lancet Digital Health thelancet.com/journals/landi…

Out now! Our Nature Medicine paper discussing the importance of understanding cellular and molecular mechanisms of damage in climate-related health outcomes to best plan interventions that mitigate harm:

nature.com/articles/s4159…

Reducing climate impact is so important to ensure the ongoing delivery of cancer care - it is fantastic that we now have a roadmap for ESMO - Eur. Oncology to reduce its carbon footprint - hopefully other organisations will follow its example

sciencedirect.com/science/articl…

The top 20 pharma companies by 2023 revenue fiercepharma.com/pharma/top-20-…

Tumor Size Is Not Everything: Advancing Radiomics as a Precision Medicine Biomarker in Oncology Drug Development and Clinical Care. A Report of a Multidisciplinary Workshop Coordinated by the RECIST Working Group | JCO Precision Oncology ascopubs.org/doi/10.1200/PO…

Can we measure programmed-death ligand 1 status in gastroesophageal cancer with PET? ow.ly/2K0K50R5LVU

#NuclearMedicine #GastricAdenocarcinoma #PETscan Memorial Sloan Kettering Cancer Center Sam Cytryn Yelena Y. Janjigian MD

Do patients with these small triple-negative tumors benefit from chemotherapy? - Paolo Tarantino

#BreastCancer #Survival #Cancer #DanaFarberCancerInstitute #NPJ #OncoDaily #Oncology

oncodaily.com/46412.html

Very proud of the team led by Prof Nagengast at our GI dept UMCG MDL who visualized #vedolizumab during #endoscopy to determine distribution in intestinal tissue and identify drug target cells GUTJournal_BMJ. Huge potential for personalized medicine #ibd gut.bmj.com/content/early/…

Clinical Benefit and Regulatory Outcomes of Cancer Drugs Receiving Accelerated Approval jamanetwork.com/journals/jama/…

#WorldHealthDay : Health is a human right, and #CancerCare is a human priority. A recent report shows that #UniversalHealthcoverage in #oncology is still not a reality. 

To know more, read Dario Trapani’s article in the #ESMODailyReporter
👉ow.ly/CeHj50R93Ia

World Health Organization (WHO)

So Intriguing, The GLP-1 receptor is expressed in vivo by human metastatic prostate cancer ncbi.nlm.nih.gov/pmc/articles/P…

The latest Ground Truths Podcast Eric Topol The GLP-1 story, from #insulin to #weightloss #obesity #heartdisease #kidney disease #Parkinsons #Alzheimers with a dash of GIP, some glucagon, a bit of neuroscience #inflammation and a look to the future youtube.com/watch?v=80ufzc…

In the latest issue! Microbial metabolite enhances immunotherapy efficacy by modulating T cell stemness in pan-cancer dlvr.it/T4rrVY

Recurrence data from the #PHERGain phase 2 trial published on The Lancet. A de-escalated, PET-response-based neoadjuvant treatment strategy for stage I-IIIA HER2+ breast cancer led to 94.8% 3-year iDFS rate and halved the incidence of severe AEs. #bcsm
thelancet.com/journals/lance…

Beautiful paper by Roberto Leon-Ferre and many others showing that pts with stage I TNBC and high TIL have an excellent survival even without chemotherapy. Happy to be part of it, many Dutch pts were included! Overtreatment is a huge problem for certain BC subgroups #bcsm OncoAlert